MeSH D004927 - escherichia coli infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Nitrofurantoin | Nitrofurantoin |  | 1982-01-01 |  |  |
| Alembic Pharmaceuticals | Nitrofurantoin | Nitrofurantoin |  | 2021-06-25 |  |  |
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 |  |  |
| Alkem Laboratories | Fosfomycin tromethamine | Fosfomycin Tromethamine |  | 2021-10-21 |  |  |
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/2
Phase 2
100%2/2
Phase 3
99%76/77
Approved: 75Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use